Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300071256Phase 4Not yet recruiting
Phase 4, randomised trial of remimazolam in cholecystitis and cholelithiasis (2 arms), sponsored by First People's Hospital of Zunyi. Primary endpoints: Induction time, Extubation time and 2 more. Planned start May 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300071256.